Literature DB >> 4044289

Preliminary report on inverse diurnal variation of phenylalanine: implications in maternal phenylketonuria.

D L Farquhar, F Steven, A Westwood.   

Abstract

Plasma phenylalanine concentrations vary throughout the day by a well-described circadian rhythm. This rhythm is altered in phenylketonuric subjects. The implications for monitoring a pregnant phenylketonuric are considered.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4044289

Source DB:  PubMed          Journal:  Hum Nutr Appl Nutr        ISSN： 0263-8495


  5 in total

1.  What Is the Best Blood Sampling Time for Metabolic Control of Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients?

Authors:  Esther van Dam; Anne Daly; Gineke Venema-Liefaard; Margreet van Rijn; Terry G J Derks; Patrick J McKiernan; M Rebecca Heiner-Fokkema; Anita MacDonald; Francjan J van Spronsen
Journal:  JIMD Rep       Date:  2017-01-25

2.  Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet.

Authors:  A MacDonald; G Rylance; S K Hall; D Asplin; I W Booth
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

Review 3.  Gestational carrier--a reproductive haven for offspring of mothers with phenylketonuria (PKU): an alternative therapy for maternal PKU.

Authors:  R O Fisch; G Tagatz; J P Stassart
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations.

Authors:  Sarah C Grünert; Corinna M Brichta; Andreas Krebs; Hans-Willi Clement; Reinhold Rauh; Christian Fleischhaker; Klaus Hennighausen; Jörn Oliver Sass; K Otfried Schwab
Journal:  Nutr J       Date:  2013-05-14       Impact factor: 3.271

5.  Administration of protein substitute and quality of control in phenylketonuria: a randomized study.

Authors:  A MacDonald; G Rylance; P Davies; D Asplin; S K Hall; I W Booth
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.